UK government and UKRI invest £54m to tackle biosecurity threats

United Kingdom | Vaccines | One Health | R&D

The UK Government and UK Research and Innovation (UKRI) announced a £54 million investment on 7 October covering 18 new research and innovation projects aimed at strengthening preparedness for future epidemics, antimicrobial resistance and animal disease threats.

A particularly important component for animal health is the development of next-generation mRNA vaccines for livestock. The programme brings together UK researchers and international collaborators across human, animal and plant health.

The funding comes as antimicrobial resistance continues to expand as a One Health challenge. UKRI notes that approximately one in six laboratory-confirmed bacterial infections globally were resistant to antibiotics in 2023.

Analyst View

The significance extends beyond UK science policy. mRNA and related programmable vaccine platforms could eventually shorten development timelines for diseases where conventional vaccine development is slow, particularly when pathogen strains evolve rapidly.

Industry Signal

Strong positive for veterinary vaccine technology, platform biotech, livestock disease preparedness and UK animal-health R&D.